Oregon Research Institute

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Oregon Research Institute sits in the top decile of US sponsors by registered trial count (#332 of 15,742 sponsors by registered trial count).

62 total trials 5 currently recruiting 55 completed early-phase tilt top decile by trial count

Oregon Research Institute: 62 sponsored US clinical trials, 5 recruiting.

Oregon Research Institute sponsors 62 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 55 completed. 0 of these trials are in Phase 3-4 (later-stage) and 16 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Delinquency, with 3 trials.

Top-decile sponsor footprint

Oregon Research Institute ranks in the top decile of sponsors by registered trial count (#332 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

A 90/100

55 of 55 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

62 total, page 2 of 2

COMPLETED NA

Targeted Obesity Prevention Program for Adolescent Females

NCT00433680
COMPLETED NA

Effectiveness of Internet-Based Cognitive Behavioral Therapy for Treating Mothers With Depression

NCT00601393
COMPLETED NA

Simplified Tai Chi for Reducing Fibromyalgia Pain

NCT01311427
COMPLETED NA

Tobacco Cessation Via Doctors of Chiropractic

NCT00386945
COMPLETED NA

Lifestyle Modification Program to Reduce Risk of Coronary Heart Disease in Latina Women With Diabetes

NCT00233259
COMPLETED Phase 2

Tobacco Cessation Via Public Health Dental Clinics

NCT00683839
COMPLETED NA

Effectiveness of a Dissonance-Based Eating Disorder Prevention Program (The Body Project II)

NCT00663754
COMPLETED Phase 1

Preventing HIV/Aids in Drug Abusing Youth

NCT00680719
COMPLETED Phase 2

Tobacco Quitlines:Adjunct to Dental Office Tobacco Intervention

NCT00384254
COMPLETED Phase 1

Transitional Treatment of Adolescents in Family Therapy

NCT00680381
COMPLETED

Enhancing Support for Women With Type 2 Diabetes: Follow-Up

NCT00680849
COMPLETED Phase 1

Comparing Tai Chi Training to a Low-Stress Physical Activity to Enhance Sleep in Older Adults

NCT00079664
← Previous Page 2 of 2

Phase Distribution

PhaseTrial count
Phase 1 8
Phase 2 8

Therapeutic Areas

Delinquency 3
Mild Cognitive Impairment 3
Tobacco Use Cessation 2
Substance Use 2
Substance Use Disorders 2
Depression 2
Obesity 2
Self Destructive Behavior 1
Trauma Exposure 1
HIV Risk 1

What is open in the Oregon Research Institute pipeline

5 recruiting of 62 indexed (8% open); 55 completed (89%).

Phase mix: 0 late (III/IV) vs 16 early (I/II) (early-phase heavy).

Top condition: Delinquency (3 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Oregon Research Institute: open-pipeline peers nationwide

Peers matched on 62 registered trials and 8% open enrollment, not the therapeutic-area sidebar.

Oregon Research Institute sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 0%2%4%6%8%10% Total trials Recruiting share Oregon Research InstitutePower Life SciencesActelionHennepin Healthcare Research InstituteUnited TherapeuticsGE HealthcareArcutis BiotherapeuticsMedtronic EndovascularNovartis Pharmaceuticals
Oregon Research Institute sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Oregon Research Institute sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 62 trials (± recruiting share)

Sponsors near 8% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Oregon Research Institute page

62 registered trials is a research-attention snapshot, not an endorsement of Oregon Research Institute or any single study.

  • 5 of Oregon Research Institute's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Delinquency is the condition Oregon Research Institute studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Delinquency trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Oregon Research Institute pipeline card: 62 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.